Chunghwa Chemical Synthesis & Biotech Co., Ltd.
1762.TW
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.72B
Close$
Share Statistics
| Market cap | $2.72 Billion |
|---|---|
| Enterprise Value | $3.16 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.39 |
| Beta | 0.51 |
| Outstanding Shares | 55,156,000 |
Return
| Return on Equity | -1.61% |
|---|---|
| Return on Assets | -1.19% |
| Return on Invested Capital | -0.85% |
Valuation & Multiples
| P/E Ratio | -38.01 |
|---|---|
| PEG | 23.51 |
| Price to Sales | 2.21 |
| Price to Book Ratio | 0.61 |
| Enterprise Value to Revenue | 3.39 |
| Enterprise Value to EBIT | -91.14 |
| Enterprise Value to Net Income | -62 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.24 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$1.20
Average shareholder expectationRevenue Estimate
$435.90 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Chunghwa Chemical Synthesis & Biotech Co., Ltd.
243 employees
CEO: Chung Hsin Huang Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of a...